Medical specialists from Japan tagged as investigators in clinical trials studying Idiopathic Thrombocytopenic Purpura
Total 11 results
-
Akira IshiguroSeen in:
- Tokyo, National Center for Child Health and Development - Investigational Site Number: 39204
Trials:- NCT04562766 (Principal Investigator)
Conditions: -
Hirokazu KashiwagiSeen in:
- Osaka, Osaka University Hospital - Investigational Site Number: 39202
Trials:- NCT04562766 (Principal Investigator)
Conditions: -
Hironori UenoSeen in:
- Tokyo, National Hospital Organization Tokyo Medical Center - Investigational Site Number: 39210
Trials:- NCT04562766 (Principal Investigator)
Conditions: -
Katsuyoshi KohSeen in:
- Saitama-shi, Local Incorporated Administrative Institution Saitama prefectural hospital organization Saitama prefectural Children's Medical Center - Investigational Site Number: 39206
Trials:- NCT04562766 (Principal Investigator)
Conditions: -
Masaki YamaguchiSeen in:
- Ishikawa, Ishikawa Prefectural Central Hospital - Investigational Site Number: 39205
Trials:- NCT04562766 (Principal Investigator)
Conditions: -
Mineo KurokawaSeen in:
- Tokyo, The University of Tokyo Hospital - Investigational Site Number: 39208
Trials:- NCT04562766 (Principal Investigator)
Conditions: -
Nobuharu KosugiSeen in:
- Tokyo, Tokyo Metropolitan Bokutoh Hospital - Investigational Site Number: 39209
Trials:- NCT04562766 (Principal Investigator)
Conditions: -
Shinya KatsutaniSeen in:
- Hiroshima City, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital - Investigational Site Number: 39203
Trials:- NCT04562766 (Principal Investigator)
Conditions: -
Takahiro SuzukiSeen in:
- Sagamihara, Kitasato University Hospital - Investigational Site Number: 39207
Trials:- NCT04562766 (Principal Investigator)
Conditions: -
Yoshihiro HattaSeen in:
- Tokyo, Itabashi, Nihon University Itabashi Hospital
Trials:- NCT04278924 (Principal Investigator)
Conditions: -
Yoshitaka MiyakawaSeen in:
- Saitama, Saitama Medical University Hospital - Investigational Site Number: 39201
Trials:- NCT04562766 (Principal Investigator)
Conditions:
Clinical Trials on Idiopathic Thrombocytopenic Purpura
-
Protalex, Inc.TerminatedPhase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITPIdiopathic Thrombocytopenic Purpura (ITP)Australia, New Zealand
-
CSL LimitedCompletedIdiopathic Thrombocytopenic Purpura (ITP)Australia
-
University Hospital, BordeauxCompletedChronic Idiopathic Thrombocytopenic Purpura | Congenital Thrombocytopenia
-
University Hospital, AngersMinistry of Health, FranceUnknownAcute Idiopathic Thrombocytopenic PurpuraFrance
-
AmgenCompletedThrombocytopenia | Immune Thrombocytopenia | Idiopathic Thrombocytopenic Purpura | Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | Thrombocytopenic PurpuraUnited States, Canada, Australia
-
Neufeld, Ellis J, MD, PhDGenentech, Inc.; Biogen; Glaser Pediatric Research Network; Terrana ITP Research...CompletedImmune Thrombocytopenic Purpura (ITP) | Idiopathic Thrombocytopenic Purpura (ITP)United States
-
Weill Medical College of Cornell UniversityGenentech, Inc.WithdrawnIdiopathic Thrombocytopenic Purpura (ITP)United States
-
Jiangsu HengRui Medicine Co., Ltd.UnknownChronic Idiopathic Thrombocytopenic PurpuraChina
-
GlaxoSmithKlineCompletedChronic Idiopathic Thrombocytopenic Purpura | Purpura, Thrombocytopenic, IdiopathicJapan
-
AmgenCompletedIdiopathic Thrombocytopenic Purpura | Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)